Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by ENDRA Life Sciences Inc.

< Previous 1 2 3 Next >
ENDRA Life Sciences Enhances TAEUS® System Intellectual Property Portfolio with Issuance of 28th U.S. Patent
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
ENDRA Life Sciences to Participate in the JMP Securities Life Sciences Conference
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
ENDRA Life Sciences Bolsters TAEUS® System Intellectual Property with Issuance of 27th U.S. Patent
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
ENDRA Life Sciences to Present at the H.C. Wainwright Global Investment Conference
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
ENDRA Life Sciences Reports First Quarter 2022 Financial Results and Provides Business Update
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
ENDRA Life Sciences Issued Additional U.S. and Chinese Patents for its TAEUS® System
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
ENDRA Life Sciences to Report First Quarter 2022 Financial Results on May 12, 2022
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
ENDRA Life Sciences Raises $8.7 Million in Gross Proceeds Through its At-The-Market Facility
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
ENDRA Life Sciences Achieves Key Quality Management System Certification
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
ENDRA Life Sciences Strengthens TAEUS® System Global Intellectual Property Protection with Issuance of 10th and 11th Chinese Patents
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
ENDRA Life Sciences to Report Fourth Quarter 2021 Financial Results on March 30, 2022
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
ENDRA Life Sciences Strengthens TAEUS® System Global Intellectual Property Portfolio with Issuance of 6th and 7th European Patents
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
ENDRA Life Sciences Provides Update on U.S. Regulatory Strategy for its TAEUS® System
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
ENDRA Life Sciences Expands into China with Shanghai General Hospital Partnership
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
ENDRA Life Sciences to Present at the H.C. Wainwright BioConnect Virtual Conference
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
ENDRA Life Sciences Announces New Clinical Study Partnership with King’s College Hospital, London
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
ENDRA Life Sciences Expands Pharmaceutical Partnerships with VGI Health Technology to Provide TAEUS for Patient Screening and Biomarker Measurement for Phase 2 Study
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
ENDRA Life Sciences Further Strengthens TAEUS® System Intellectual Property with Issuance of 22nd and 23rd U.S. Patents
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
ENDRA Life Sciences Reports Third Quarter 2021 Financial Results and Provides Business Update
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
ENDRA Life Sciences to Report Third Quarter 2021 Financial Results on November 15, 2021
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
ENDRA Life Sciences Further Strengthens TAEUS® System Intellectual Property Protection with Issuance of 21st U.S. Patent
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
ENDRA Life Sciences to Participate in the H.C. Wainwright 5th Annual NASH Investor Conference
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
ENDRA Life Sciences to Participate in Two Upcoming Investment Conferences
From ENDRA Life Sciences Inc.
Via AccessWire
Tickers NDRA
ENDRA Life Sciences Reports Second Quarter 2021 Financial Results and Provides Business Update
From ENDRA Life Sciences Inc.
Via AccessWire
Topics Intellectual Property Regulatory Compliance
Tickers NDRA
ENDRA Life Sciences to Report Second Quarter 2021 Financial Results on August 12, 2021
From ENDRA Life Sciences Inc.
Via AccessWire
Tickers NDRA
ENDRA Life Sciences Announces Participation in A.G.P.'s Virtual MedTech Summer Conference on July 29, 2021
From ENDRA Life Sciences Inc.
Via AccessWire
Tickers NDRA
ENDRA Life Sciences Strengthens TAEUS(R) System Intellectual Property Protection with the Issuance of Three U.S. Patents
From ENDRA Life Sciences Inc.
Via AccessWire
Topics Intellectual Property
Tickers NDRA
ENDRA Life Sciences Appoints Irina Pestrikova as Senior Director of Finance, Announces Departure of CFO David Wells
From ENDRA Life Sciences Inc.
Via AccessWire
Topics Initial Public Offering Intellectual Property Regulatory Compliance
Tickers NDRA
ENDRA Life Sciences Set to Join the Russell Microcap(R) Index
From ENDRA Life Sciences Inc.
Via AccessWire
Topics Derivatives Intellectual Property
Tickers NDRA
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.